BDBM767421 4-[[4-fluoro-3-[4-[4-[[2-(2- hydroxyethyl)-3-oxo-1-(2- pyridyl)pyrazolo[3,4-d]pyrimidin-6- yl]amino]phenyl]piperazine-1- carbonyl]phenyl]methyl]-2H- phthalazin-1-one::US20250270212, Compound 15

SMILES O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(c2ccc(Nc3ncc4c(=O)n(CCO)n(-c5ccccn5)c4n3)cc2)CC1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 767421   

TargetWee1-like protein kinase(Human)
Padarn Therapeutics

US Patent
LigandPNGBDBM767421(4-[[4-fluoro-3-[4-[4-[[2-(2- hydroxyethyl)-3-oxo-1...)
Affinity DataEC50:  550nMAssay Description:The enzymatic assay used to determine activity was a Luminescence assay using a Microplate Reader (BMG, ClarioStar Plus). The enzymatic reaction was ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent